HOME >> BIOLOGY >> NEWS
Earliest evidence of humans affecting aquatic ecology in Canada, United States

(Kingston, ON) New findings from Canadian scientists dispel the belief that European settlers were the first humans to cause major changes to Canadian and U.S. freshwater ecosystems.

A University of Toronto-led, multidisciplinary team including researchers from Queen's, McGill, and University of Ottawa show for the first time that prehistoric Inuit whalers dramatically altered high Arctic pond ecosystems through their hunting practices eight centuries ago a legacy that is still evident today.

The principal investigator on the team, U of T Geology Professor Marianne Douglas, is currently in Antarctica using the same kind of detection techniques to study climate change there.

"Our findings are an example of a long-term human intervention in a place where you really don't expect it," says Queen's Biology Professor John Smol, Canada Research Chair in Environmental Change and co-head of the university's Paleoecological Environmental Assessment and Research Laboratory (PEARL). "It seems totally ironic since we tend to think of the high Arctic as being unaffected by humans locally."

Results of the study will be published in the Proceedings of the National Academy of Sciences on-line early edition the week of Jan 26.

The researchers conducted their study on Somerset Island in the Canadian Arctic, where prehistoric Thule whalers (ancestors of the present day Inuit) had the highest concentration of settlement between 400 and 800 years ago. They brought with them a well-developed whaling technology that included large open skin boats, whaling harpoons and lances, and seal skin floats. A semi-nomadic people, the Thule settled in temporary camps each summer, and in the winter returned to semi-permanent villages constructed partially from whalebone.

According to James Savelle, the McGill University archeologist on the research team, while the number of bowheads killed each year would have varied, during the more productive whaling
'"/>

Contact: Nancy Dorrance
dorrance@post.queensu.ca
613-533-2869
Queen's University
26-Jan-2004


Page: 1 2 3

Related biology news :

1. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
2. Earliest European modern humans found
3. Earliest evidence of lemurs discovered in Pakistan, far from their current home, Science reports
4. Earliest human ancestors discovered in Ethiopia
5. Earliest chewing herbivore ever found spurred vertebrate life on land, scientists find
6. Earliest Modern Tree Lived 360-345 Million Years Ago
7. Evidence For Earliest Maritime-Based Societies In The Americas Reported In Science Magazine
8. New evidence of radiation risk in childhood leukaemia
9. Oldest evidence for processing of wild cereals: starch grains from barley, wheat, on grinding stone
10. Study finds first evidence COX-2 enzymes can regulate DNA damage
11. Researchers find evidence that sea turtles navigate with magnetic maps

Post Your Comments:
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: